Energenesis Biomedical Co., Ltd.
Quick facts
Marketed products
- Regaine · Other
Phase 3 pipeline
- ENERGI-F703 GEL · Dermatology / Wound Care
ENERGI-F703 is a topical gel formulation designed to promote wound healing and tissue regeneration through growth factor delivery. - ENERGI-F703 GEL matched vehicle · Dermatology/Wound Care
ENERGI-F703 is a topical gel formulation designed to promote wound healing and tissue repair through enhanced cellular regeneration.
Phase 2 pipeline
- ENERGI-F701 · Diabetes
ENERGI-F701 is a small molecule that targets the SGLT2 receptor.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: